Amgen Inc. (AMGN) FY2025 Annual P&L / Income Statement

Amgen Inc. (AMGN) FY2025 Annual P&L / Income Statement

Income statement for 2025-01-01 through 2025-12-31. View: Product and service (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

36,751,000,000 US dollars

Cost of sales

12,037,000,000 US dollars

Gross profit (calculated)

24,714,000,000 US dollars

Operating expenses (calculated)

15,634,000,000 US dollars

Operating income

9,080,000,000 US dollars

Other income (expense), net (calculated)

negative 104,000,000 US dollars

Total income before income taxes

8,976,000,000 US dollars

Provision for income taxes

1,265,000,000 US dollars

Net income

7,711,000,000 US dollars

Product sales

35,148,000,000 US dollars

Other revenues

1,603,000,000 US dollars

Research and development

7,272,000,000 US dollars

Selling, general and administrative

7,050,000,000 US dollars

Other

1,312,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.